Your browser doesn't support javascript.
loading
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.
Rosenbaum, Evan; Chugh, Rashmi; Ryan, Christopher W; Agulnik, Mark; Milhem, Mohammed M; George, Suzanne; Jones, Robin L; Chmielowski, Bartosz; Van Tine, Brian A; Tawbi, Hussein; Elias, Anthony D; Read, William L; Budd, G Thomas; Qin, Li-Xuan; Rodler, Eve T; Hirman, Joe; Weiden, Paul; Bennett, Cathryn M; Livingston, Philip O; Ragupathi, Govind; Hansen, David; D'Angelo, Sandra P; Tap, William D; Schwartz, Gary K; Maki, Robert G; Carvajal, Richard D.
Afiliação
  • Rosenbaum E; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical Center, New York, NY, USA.
  • Chugh R; University of Michigan, Ann Arbor, MI, USA.
  • Ryan CW; Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Agulnik M; City of Hope, Duarte, CA, USA.
  • Milhem MM; University of Iowa and Clinic Holden Cancer Center, Iowa City, IA, USA.
  • George S; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jones RL; Royal Marsden/Institute of Cancer Research, London, GB. Previous Affiliation: University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chmielowski B; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Van Tine BA; Washington University in Saint Louis, Saint Louis, MO, USA.
  • Tawbi H; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Elias AD; University of Colorado Cancer Center, Aurora, CO, USA.
  • Read WL; Emory University, Atlanta, GA, USA.
  • Budd GT; Cleveland Clinic, Cleveland, OH, USA.
  • Qin LX; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Rodler ET; UC Davis Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Hirman J; Pacific Northwest Statistical Consulting, Inc, USA.
  • Weiden P; BioPharma Consulting Services, LLC, USA.
  • Bennett CM; BioPharma Consulting Services, LLC, USA.
  • Livingston PO; MabVax Therapeutics, Inc., USA.
  • Ragupathi G; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Hansen D; MabVax Therapeutics, Inc., USA.
  • D'Angelo SP; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical Center, New York, NY, USA.
  • Tap WD; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical Center, New York, NY, USA.
  • Schwartz GK; Columbia University Medical Center, New York, NY, USA.
  • Maki RG; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA.
  • Carvajal RD; Columbia University Medical Center, New York, NY, USA. Electronic address: carvajalr@columbia.edu.
Eur J Cancer ; 176: 155-163, 2022 11.
Article em En | MEDLINE | ID: mdl-36215947
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Vacinas / Segunda Neoplasia Primária Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Vacinas / Segunda Neoplasia Primária Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article